|« Previous month||Next month »|
30-Jun-2011 - in-Pharmatechnologist.com presents a round up of developments in the pharmaceutical manufacturing space with news from Dendreon, Amcor and Cody Labs.
30-Jun-2011 - The glass packaging industry in Europe posted a 3.5 per cent year-on year production increase to 20.7m tonnes in 2010 as output partially recovered from its 2009 slump.
30-Jun-2011 - Par Pharmaceutical will cut 100 jobs at its proprietary products division Strativa Pharmaceuticals as part of a restructuring plan designed to save as much as $12m.
30-Jun-2011 - Prosonix has secured funding to move its pipeline of proprietary mono and multi-component combination respiratory therapies through clinical development.
29-Jun-2011 - US drug giant Pfizer has exercised its option to re-acquire a manufacturing facility in Rouses Point, New York from Akrimax.
29-Jun-2011 - DSM Biologicals has launched a new production method designed to streamline downstream processing during biopharmaceutical manufacturing that, it claims, makes making mAB-based drugs more cost effective.
29-Jun-2011 - in-PharmaTechnologist.com presents its latest round up of movements in the pharma sector, including appointments at Soligenx, Arno Therapeutics, Euthymics and Aeris Therapeutics.
28-Jun-2011 - Australia’s CSL Biotherapies has received a warning letter from the US FDA for GMP deviations at its vaccine production plant in Parkville, Victoria.
28-Jun-2011 - The European Directorate for the Quality of Medicines and Healthcare (EDQM) issued a new batch of CEP for drug products.
28-Jun-2011 - Sanofi Pasteur has opened a new centre in Canada in an effort to streamline its global vaccine R&D operations.
28-Jun-2011 - Gerresheimer will expand its pharmaceutical packaging plant in the Czech Republic to meet growing demand for plastic systems and to further expand a key training hub.
27-Jun-2011 - BioMarin will buy Pfizer’s biologics manufacturing plant in Shanbally, Cork, Ireland to add production capacity for its candidate mucopolysaccharidosis treatment.
27-Jun-2011 - The Pharmaceutical Research and Manufacturers of America (PhRMA) has welcomed proposed changes to US patent laws that would alter the basis for patent awards.
23-Jun-2011 - Social media can play a role in ensuring that medicines are safe, but regulatory input is needed according to the Drug Safety Alliance (DSA).
23-Jun-2011 - Watson Pharmaceuticals has initiated a $44m (€31m) expansion of its Utah R&D and manufacturing plant for transdermal patches and topical gels.
23-Jun-2011 - Novartis has started work on a manufacturing plant in St Petersburg in the first stage of a $500m investment in the Russian pharmaceutical industry.
22-Jun-2011 - Lonza has launched a new process development and material supply service designed for the discovery and early development market.
22-Jun-2011 - The FDA has outlined its plan to ensure the quality of products imported into the US, including working more closely with regulators and industry.
21-Jun-2011 - The EMA has proposed to the FDA that European inspections of US manufacturing plants are waived when certain criteria are met.
21-Jun-2011 - Processing technology firm Pall Life Sciences has introduced a 200L version of its Allegro single-use mixer for biopharmaceutical manufacturing.
20-Jun-2011 - Catalent Pharma Solutions and German expression system developer Cevec Pharmaceuticals have partnered to create a cell development service that, they claim, will help drugmakers generate stable lines faster.
20-Jun-2011 - Dr Reddy's Mexican API production plant has received an FDA warning letter that details failures to validate analytical methods and other problems.
20-Jun-2011 - Grindeks has opened a 2,300 sq m API production plant in Latvia that will boost UDCA sales to €10m ($14m) a year when at full capacity.
16-Jun-2011 - Mystic Pharmaceuticals has been awarded a US patent for a manufacturing technology that is critical to its biologics delivery platform.
16-Jun-2011 - US drugmaker APP Pharmaceuticals will invest $38m to boost its manufacturing capacity for injectable generic drugs at its facility in Grand Island.
|« Previous month||Next month »|